Externalisation of phosphatidylserine following the treatment of cancer cells with radiotherapy or cell cycle inhibitors was found to closely correlate with resistance to perforin and lymphocyte cytotoxicity, despite normal recognition and activation by NK cells and CAR T cells (68). Here, PRF1 is linked to cancer.